3Bruttomesso D, Pianta A, Mari A et al . Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48:99 - 105.
4Polonsky KS, Given BD, Hirsch L et al . Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988,81:435 - 441.
5Bonnadonna RC,Cretti A,Brunato B et al . Metabolic features of impaired glucose regulation in Caucasians. Diabetologia, 2000, 43 ( 1 ) :A16.5.
6Lundgren H, Bengtsson C, Blohme, G et al . Fasting serum inulin concentration and early insulin response as risk determinants for developing diabetes. Diabet Med, 1990,7:407 - 413.
7Ryan EA, Imes S, Liu D et al . Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes, 1995,44:506-512.
8Byme MM, Sturis J, Sobel RJ et al . Elevated plasma glucose 2 h postchallenge predicts defects inβ - cell function. Am J Physiol, 1996,270: 572 - 579.
9Bergstrom RW, Wahl PW, Leonetti DL et al . Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab, 1990, 71 : 1447- 1453.
10Quddusi S, Vahl TP, Hanson K et al . Differential effects of acute and extended infusions of glucagons - like peptide - 1 on first - and second - phase insulin secretion in diabetic and noraliabetic humans. Diabetes Care 2003,26:791 - 798.
8Westerhaus B,Gosmanov AR,Umpierrez GE.Diabetesprevention:can insulin secretagogues do the job[J].PrimCare Diabetes,2011,5(2):73-80.
9Malaisse WJ.Meglitinide analogs:new insulinotropic a-gents for the treatment of non-insulin dependent diabetes[J].Rev Med Brux,2003,24(3):162-168.
10Hanefeld M,Bouter KP,Dickinson S,et al.Rapid andshortacting mealtime insulin secretion with nateglinidecontrols both prandial and mean glycemia[J].DiabetesCare,2000,23(2):202-207.
